Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantifying factors for the success of stratified medicine.

Nature reviews. Drug discovery·2011

Same author

Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake.

Nuclear medicine and biology·2009

Same author

Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2004

Same author

The nonuniformity of antibody distribution in the kidney and its influence on dosimetry.

Radiation research·2003

Same author

Synergy between vascular targeting agents and antibody-directed therapy.

International journal of radiation oncology, biology, physics·2002

Same author

Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.

European journal of nuclear medicine and molecular imaging·2002

Search research articles

Related Experiment Video

Updated: May 29, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Pharmacogenetics: practices and opportunities for study design and data analysis.

Aiden A Flynn¹

¹Exploristics Limited, Cromac Square, Belfast BT28LA, United Kingdom. aiden.flynn@exploristics.com

Drug Discovery Today

|August 31, 2011

Summary

This summary is machine-generated.

Pharmacogenetics (PGx) research shows promise for personalized medicine but requires technical and educational advancements. Future studies can improve genetic effect identification by integrating diverse data sources.

Related Experiment Videos

Last Updated: May 29, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

Pharmacogenetics
Genomics
Personalized Medicine

Background:

Pharmacogenetics (PGx) is crucial for tailoring treatments to individual patient needs.
Widespread clinical adoption of PGx is hindered by technical, methodological, and educational barriers.

Purpose of the Study:

To review the current landscape of pharmacogenetics research.
To highlight recent advancements in prospective study design.
To identify practical strategies for enhancing the detection of genetic effects.

Main Methods:

Review of current pharmacogenetics research scope.
Inclusion of a case study to illustrate limitations and solutions.
Discussion of data integration strategies for exploratory research.

Main Results:

Pharmacogenetics has demonstrated clinical utility in specific areas.
Current practices have limitations in identifying genetic effects.
Opportunities exist for improving PGx research through data integration.

Conclusions:

Further technical and methodological advancements are essential for broader pharmacogenetics implementation.
Educating clinical researchers on PGx value is critical.
Integrating diverse data sources can enhance exploratory pharmacogenetics research and its clinical application.